Theraclion S.A.
PAR: ALTHE.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Martin Deterre
- Employees
- 28
- Headquarters
- Malakoff, France
- IPO year
- 2014
- Market cap
- €27.8M
- Website
- https://www.theraclion.com
Loading ALTHE…
Loading profile data…Frequently asked questions about ALTHE
What does Theraclion S.A. (ALTHE.PA) do?
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installe...
Where does ALTHE.PA trade?
Theraclion S.A. (ALTHE.PA) trades on the Euronext Paris.
What sector is ALTHE.PA in?
Theraclion S.A. (ALTHE.PA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Theraclion S.A.?
Martin Deterre is the chief executive officer of Theraclion S.A. (ALTHE.PA).
Where is Theraclion S.A. headquartered?
Theraclion S.A. is headquartered in France.
Does ALTHE.PA pay a dividend?
Theraclion S.A. (ALTHE.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALTHE.PA go public?
Theraclion S.A. (ALTHE.PA) completed its initial public offering in 2014.